Jazz Pharmaceuticals plc
JAZZ
$125.22
-$0.94-0.75%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -676.38% | -148.42% | -11.13% | 27.58% | 1,253.15% |
| Total Depreciation and Amortization | 5.54% | -2.10% | 1.93% | 1.35% | -0.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,280.96% | -41.55% | 165.33% | 68.86% | -57.21% |
| Change in Net Operating Assets | -213.62% | 460.19% | -202.98% | 1.58% | -147.53% |
| Cash from Operations | -79.33% | 7.83% | -0.04% | 20.34% | 24.00% |
| Capital Expenditure | 6.58% | -4.47% | -23.16% | -52.14% | -2.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 248.34% | 13.86% | -180.04% | 189.95% | 5.66% |
| Cash from Investing | -279.46% | 12.60% | -190.28% | 183.27% | 5.45% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | 98.98% | -9,677.42% | 98.67% | -7,419.35% | 0.00% |
| Issuance of Common Stock | -8.30% | 24.48% | 53,994.12% | -99.84% | 2,114.57% |
| Repurchase of Common Stock | -89.50% | -1,576.98% | 97.36% | 7.71% | -233.24% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 84.69% | -9,730.40% | -103.36% | 252.98% | -184.84% |
| Foreign Exchange rate Adjustments | 172.80% | 174.05% | -174.54% | 504.61% | 55.30% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.99% | -382.92% | -77.42% | 1,084.59% | -39.19% |